The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study
Open accessAbstract
Microglial activation is implicated in the pathogenesis of ALS and can be detected in animal models of the disease that demonstrate increased survival when treated with anti-inflammatory drugs. PK11195 is a ligand for the "peripheral benzodiazepine binding site" expressed by activated microglia. Ten ALS patients and 14 healthy controls underwent [(11)C](R)-PK11195 PET of the brain. Volumes of interest were defined to obtain [(11)C](R)-PK11195 regional binding potential values for motor and "extra-motor" regions. Significantly increased binding was found in motor cortex (P = 0.003), pons (P = 0.004), dorsolateral prefrontal cortex (P = 0.010) and thalamus (P = 0.005) in the ALS patients, with significant correlation between binding in the motor cortex and the burden of upper motor neuron signs clinically (r = 0.73, P = 0.009). These findings indicate that cerebral microglial activation can be detected in vivo during the evolution of ALS, and support the previous observations that cerebral pathology is widespread. They also argue for the development of therapeutic strategies aimed at inflammatory pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“presumably due to increased CNS microglia or their activation, as suggested by positron emission tomography (PET) imaging using radiotracers specific for activated microglia [423,424].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [424]
In the citing paper
“Postmortem studies308–310 and in vivo PET studies311–313 revealed widespread cerebral microglial activation in patients with ALS,308–312 and even in pre-symptomatic ALS-related mutation carriers.309,313”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [311]
In the citing paper
“Microglial activation in middle frontal and superior or middle temporal gyrus regions was also highly found in vivo PET imaging studies in humans”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [311]
Citations
Cites
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Kyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,400
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307
Simplified Reference Tissue Model for PET Receptor Studies
Lammertsma, A. A., & Hume, S. P. (1996) · NeuroImage · doi:10.1006/nimg.1996.0066 · Cited by 2,025
Rowland, L. P., & Shneider, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442207 · Cited by 1,913
From charcot to lou gehrig: deciphering selective motor neuron death in als
Cleveland, D. W., & Rothstein, J. D. (2001) · Nature reviews. Neuroscience · doi:10.1038/35097565 · Cited by 1,389
Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model
Gunn, R. N., Lammertsma, A. A., Hume, S. P., & Cunningham, V. J. (1997) · NeuroImage · doi:10.1006/nimg.1997.0303 · Cited by 1,085
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V. O., Li, M., Sarang, S. S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,069
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054
Self-citationThe overlap of amyotrophic lateral sclerosis and frontotemporal dementia
Lomen, C. E., Anderson, T. T., & Miller, B. L. (2002) · Neurology · doi:10.1212/wnl.59.7.1077 · Cited by 699
Cited by
Sorted by citations
Items 201–300 of 737
Tan, H. Y., Yong, Y. K., Xue, Y. C., Liu, H., Furihata, T., Shankar, E. M., & Ng, C. S. (2022) · iScience · doi:10.1016/j.isci.2022.104404 · Cited by 73
Biomarkers in Amyotrophic Lateral Sclerosis
Pradat, P., & Dib, M. (2009) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256320 · Cited by 71
Functional overlap and divergence between ALS and bvFTD
Trojsi, F., Esposito, F., Stefano, M. D., Buonanno, D., Conforti, F. L., Corbo, D., Piccirillo, G., Cirillo, M., Monsurrò, M. R., Montella, P., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.025 · Cited by 72
In vivo evidence for microglial activation in neurodegenerative dementia
Cagnin, A., Kassiou, M., Meikle, S. R., & Banati, R. B. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00694.x · Cited by 71
Self-citationWhat Does Imaging Reveal About the Pathology of Amyotrophic Lateral Sclerosis?
Turner, M. R., & Verstraete, E. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0569-6 · Cited by 71
Self-citationPET tracers for the peripheral benzodiazepine receptor and uses thereof
Schweitzer, P. J., Fallon, B. A., Mann, J. J., & Kumar, J. S. D. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.08.012 · Cited by 70
Myelin imaging in amyotrophic and primary lateral sclerosis
Kolind, S., Sharma, R., Knight, S., Johansen‐Berg, H., Talbot, K., & Turner, M. R. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.794843 · Cited by 70
Self-citationPattern of spread and prognosis in lower limb-onset ALS
Turner, M. R., Brockington, A., Scaber, J., Hollinger, H. C., Marsden, R., Shaw, P. J., & Talbot, K. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960903420140 · Cited by 70
Self-citationIn vivo PET imaging of neuroinflammation in Alzheimer’s disease
Lagarde, J., Sarazin, M., & Bottlaender, M. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1731-x · Cited by 79
Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis
Potenza, R. L., De Simone, R., Armida, M., Mazziotti, V., Pèzzola, A., Popoli, P., & Minghetti, L. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0462-2 · Cited by 69
Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS
Tsekrekou, M., Giannakou, M., Papanikolopoulou, K., & Σκρέτας, Γ. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1383453 · Cited by 71
Boutin, H., Chauveau, F., Thominiaux, C., Kühnast, B., Grégoire, M., Jan, S., Trébossen, R., Dollé, F., Tavitian, B., Mattner, F., et al. (2007) · Glia · doi:10.1002/glia.20562 · Cited by 68
Chen, M., & Guilarte, T. R. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj172 · Cited by 70
Vicidomini, C., Panico, M., Greco, A., Gargiulo, S., Coda, A. R. D., Zannetti, A., Gramanzini, M., Roviello, G. N., Quarantelli, M., Alfano, B., et al. (2014) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2014.11.009 · Cited by 70
Structural and functional brain connectome in motor neuron diseases
Basaia, S., Agosta, F., Cividini, C., Trojsi, F., Riva, N., Spinelli, E. G., Moglia, C., Femiano, C., Castelnovo, V., Canu, E., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010731 · Cited by 68
The Role of Osteopontin in Microglia Biology: Current Concepts and Future Perspectives
Rosmus, D.-D., Lange, C., Ludwig, F., Ajami, B., & Wieghofer, P. (2022) · Biomedicines · doi:10.3390/biomedicines10040840 · Cited by 70
Interleukin-1 Antagonist Anakinra in Amyotrophic Lateral Sclerosis—A Pilot Study
Maier, A., Deigendesch, N., Müller, K., Weishaupt, J. H., Krannich, A., Röhle, R., Meissner, F., Molawi, K., Münch, C., Holm, T., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139684 · Cited by 66
Brohawn, D. G., O’Brien, L. C., & Bennett, J. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160520 · Cited by 65
Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis
Liu, Z., Cheng, X., Zhong, S., Zhang, X., Liu, C., Liu, F., & Zhao, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00575 · Cited by 68
Molecular Mechanisms Underlying Neuroinflammation Elicited by Occupational Injuries and Toxicants
Pathak, D., & Sriram, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032272 · Cited by 72
Canu, E., Agosta, F., Riva, N., Sala, S., Prelle, A. C., Caputo, D., Perini, M., Comı, G., & Filippi, M. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2469 · Cited by 66
Pathology of callosal damage in ALS: An ex-vivo, 7 T diffusion tensor MRI study
Cárdenas, A. M., Sarlls, J. E., Kwan, J. Y., Bageac, D. V., Gala, Z. S., Danielian, L. E., Ray‐Chaudhury, A., Wang, H., Miller, K. L., Foxley, S., et al. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.04.024 · Cited by 64
Geevasinga, N., Menon, P., Sue, C. M., Kumar, K. R., Ng, K., Yiannikas, C., Kiernan, M. C., & Vucic, S. (2015) · European Journal of Neurology · doi:10.1111/ene.12669 · Cited by 64
1H MRS of basal ganglia and thalamus in amyotrophic lateral sclerosis
Sharma, K. R., Saigal, G. M., Maudsley, A. A., & Govind, V. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1687 · Cited by 65
Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis
Vucic, S., Krishnan, A. V., & Kiernan, M. C. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.112078 · Cited by 63
Structural and functional brain signatures of C9orf72 in motor neuron disease
Agosta, F., Ferraro, P. M., Riva, N., Spinelli, E. G., Domi, T., Carrera, P., Copetti, M., Falzone, Y., Ferrari, M., Lunetta, C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.05.024 · Cited by 65
Reinhardt, L., Kordes, S., Reinhardt, P., Glatza, M., Baumann, M., Drexler, H. C. A., Menninger, S., Zischinsky, G., Eickhoff, J., Froeb, C., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.01.015 · Cited by 63
Beers, D. R., Zhao, W., Neal, D. W., Thonhoff, J. R., Thome, A. D., Faridar, A., Wen, S., Wang, J., & Appel, S. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-72247-5 · Cited by 63
Huang, Q., Wang, Y., Chen, S., & Liang, F. (2023) · Aging and disease · doi:10.14336/ad.2023.0807 · Cited by 62
Mir, M., Asensio, V. J., Tolosa, L., Gou-Fàbregas, M., Soler, R. M., Lladó, J., & Olmos, G. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.049 · Cited by 62
Venneti, S., Wagner, A. K., Wang, G. K., Slagel, S., Chen, X., Lopresti, B. J., Mathis, C. A., & Wiley, C. A. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.06.003 · Cited by 62
Advances in the application of MRI to amyotrophic lateral sclerosis
Turner, M. R., & Modo, M. (2010) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2010.536836 · Cited by 61
Self-citationThe Links between ALS and NF-κB
Källstig, E., McCabe, B. D., & Schneider, B. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083875 · Cited by 60
Immune mechanisms and shared immune targets in neurodegenerative diseases
Weiner, H. L. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01046-7 · Cited by 72
MCP1-CCR2 and neuroinflammation in the ALS motor cortex with TDP-43 pathology
Jara, J. H., Gautam, M., Koçak, N., Xie, E. F., Mao, Q., Bigio, E. H., & Özdi̇nler, P. H. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1589-y · Cited by 59
The Role of the Classical Complement Cascade in Synapse Loss During Development and Glaucoma
Rosen, A. M., & Stevens, B. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-5635-4_6 · Cited by 60
Riva, N., Gentile, F., Cerri, F., Gallia, F., Podini, P., Dina, G., Falzone, Y., Fazio, R., Lunetta, C., Calvo, A., et al. (2021) · Brain · doi:10.1093/brain/awab285 · Cited by 59
Inflammatory Risk Factors and Pathologies Associated with Alzheimers Disease
Sastre, M., Richardson, J. C., Gentleman, S., & Brooks, D. J. (2011) · Current Alzheimer Research · doi:10.2174/156720511795256062 · Cited by 59
Self-citationRatai, E., Alshikho, M. J., Zürcher, N. R., Loggia, M. L., Cebulla, C. L., Cernasov, P., Reynolds, B., Fish, J., Seth, R., Babu, S., et al. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.08.007 · Cited by 62
Diagnostic criteria in amyotrophic lateral sclerosis
Geevasinga, N., Menon, P., Scherman, D. B., Simon, N. G., Yiannikas, C., Henderson, R. D., Kiernan, M. C., & Vucic, S. (2016) · Neurology · doi:10.1212/wnl.0000000000002988 · Cited by 58
TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study
Weehaeghe, D. V., Schoor, E. V., Vocht, J. D., Koole, M. J. B., Attili, B. N. N. R., Celen, S., Declercq, L., Thal, D. R., Damme, P. V., Bormans, G. M., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.231985 · Cited by 58
The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases
Feng, Y.-S., Tan, Z., Wu, L., Dong, F., & Zhang, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111428 · Cited by 59
Diagnostic utility of cortical excitability studies in amyotrophic lateral sclerosis
Geevasinga, N., Menon, P., Yiannikas, C., Kiernan, M. C., & Vucic, S. (2014) · European Journal of Neurology · doi:10.1111/ene.12422 · Cited by 56
Arlicot, N., Katsifis, A. G., Garreau, L., Mattner, F., Vergote, J., Duval, S., Bodard, S., Guilloteau, D., & Chalon, S. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0834-x · Cited by 56
Kropholler, M. A., Boellaard, R., van Berckel, B. N. M., Schuitemaker, A., Kloet, R. W., Lubberink, M., Jonker, C., Scheltens, P., & Lammertsma, A. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600488 · Cited by 56
Impaired activation of ALS monocytes by exosomes
Zondler, L., Feiler, M. S., Freischmidt, A., Ruf, W. P., Ludolph, A. C., Danzer, K. M., & Weishaupt, J. H. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.89 · Cited by 57
11 C‐PK11195 PET–based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis
Tondo, G., Iaccarino, L., Cerami, C., Vanoli, G. E., Presotto, L., Masiello, V., Coliva, A., Salvi, F., Bartolomei, I., Mosca, L., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51112 · Cited by 56
“In the first (11)C-PK11195 PET study in ALS, Turner and colleagues showed significant microglial activation in the motor cortex, pons, dorsolateral prefrontal cortex, and thalamus in 10 ALS patients compared to controls.(39) More recent studies involving second-generation TSPO tracers, that is, (18)F-DPA-714 and (11)C…”
ResultMRI signatures of the frontotemporal lobar degeneration continuum
Agosta, F., Galantucci, S., Magnani, G., Marcone, A., Martinelli, D., Volonté, M. A., Riva, N., Iannaccone, S., Ferraro, P. M., Caso, F., et al. (2015) · Human Brain Mapping · doi:10.1002/hbm.22794 · Cited by 58
Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosis
Foerster, B. R., Carlos, R. C., Dwamena, B. A., Callaghan, B. C., Petrou, M., Edden, R. A. E., Mohamed, M. A., Welsh, R. C., Barker, P. B., Feldman, E. L., et al. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.30 · Cited by 55
High-Resolution 7T MR Imaging of the Motor Cortex in Amyotrophic Lateral Sclerosis
Cosottini, M., Donatelli, G., Costagli, M., Ienco, E. C., Frosini, D., Pesaresi, I., Biagi, L., Siciliano, G., & Tosetti, M. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4562 · Cited by 55
Weehaeghe, D. V., Ceccarini, J., Delva, A., Robberecht, W., Damme, P. V., & Laere, K. V. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.166272 · Cited by 55
Nerella, S. G., Bhattacharya, A., Joshi, R. K., Nagaraj, C., Bharath, R. D., & Kumar, P. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01053 · Cited by 59
Drug discovery and amyotrophic lateral sclerosis: Emerging challenges and therapeutic opportunities
Soares, P., Silva, C., Chavarria, D., Silva, F. S. G., Oliveira, P. J., & Borges, F. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101790 · Cited by 56
Resting state fMRI correlates of Theory of Mind impairment in amyotrophic lateral sclerosis
Trojsi, F., Nardo, F. D., Santangelo, G., Siciliano, M., Femiano, C., Passaniti, C., Caiazzo, G., Fratello, M., Cirillo, M., Monsurrò, M. R., et al. (2017) · Cortex · doi:10.1016/j.cortex.2017.09.016 · Cited by 54
Quantitative patterns of motor cortex proteinopathy across ALS genotypes
Nolan, M., Scott, C., Pallebage‐Gamarallage, M. M., Lunn, D., Carpenter, K., McDonough, E., Meyer, D. E., Kaanumalle, S., Santamaría-Pang, A., Turner, M. R., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00961-2 · Cited by 55
Self-citationInterplay between immunity and amyotrophic lateral sclerosis: Clinical impact
Marchi, F. D., Munitić, I., Amedei, A., Berry, J. D., Feldman, E. L., Aronica, E., Nardo, G., Weehaeghe, D. V., Niccolai, E., Prtenjača, N., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.027 · Cited by 52
Systems biology of neurodegenerative diseases
Wood, L. B., Winslow, A. R., & Strasser, S. D. (2015) · Integrative Biology · doi:10.1039/c5ib00031a · Cited by 56
Stem Cell-Derived Motor Neurons: Applications and Challenges in Amyotrophic Lateral Sclerosis
Thonhoff, J. R., Ojeda, L. D., & Wu, P. (2009) · Current Stem Cell Research & Therapy · doi:10.2174/157488809789057392 · Cited by 53
Glial biomarkers in human central nervous system disease
Garden, G. A., & Campbell, B. M. (2016) · Glia · doi:10.1002/glia.22998 · Cited by 59
Berry, J. D., Paganoni, S., Atassi, N., Macklin, E. A., Goyal, N., Rivner, M. H., Simpson, E. P., Appel, S. H., Grasso, D., Mejia, N. I., et al. (2017) · Muscle & Nerve · doi:10.1002/mus.25733 · Cited by 53
Evidence for an early innate immune response in the motor cortex of ALS
Jara, J. H., Genç, B., Stanford, M. J., Pytel, P., Roos, R. P., Weıntraub, S., Mesulam, M. M., Bigio, E. H., Miller, R. J., & Özdi̇nler, P. H. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0896-4 · Cited by 58
Motor neuron–immune interactions: the vicious circle of ALS
Barbeito, A. G., Mesci, P., & Boillée, S. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0429-0 · Cited by 57
Resting state functional connectivity alterations in primary lateral sclerosis
Agosta, F., Canu, E., Inuggi, A., Chiò, A., Riva, N., Silani, V., Calvo, A., Messina, S., Falini, A., Comı, G., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.041 · Cited by 52
Glybina, I. V., Kennedy, A., Ashton, P., Abrams, G. W., & Iezzi, R. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4492 · Cited by 52
The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis
Cox, L. M., Calcagno, N., Gauthier, C., Madore, C., Butovsky, O., & Weiner, H. L. (2022) · Microbiome · doi:10.1186/s40168-022-01232-z · Cited by 53
Poppe, L., Rué, L., Robberecht, W., & Bosch, L. V. D. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.07.001 · Cited by 54
Emerging drugs for amyotrophic lateral sclerosis
Habib, A. A., & Mitsumoto, H. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.604312 · Cited by 52
Mills' and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET
Turner, M. R. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.047902 · Cited by 52
Self-citationRegulation of microglia by glutamate and its signal pathway in neurodegenerative diseases
Zhang, X., Wang, D., Zhang, B., Zhu, J., Zhou, Z., & Cui, L. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.04.001 · Cited by 53
You, J., Youssef, M., Santos, J. R., Lee, J., & Park, J. (2023) · Biology · doi:10.3390/biology12101307 · Cited by 60
Extramotor Damage Is Associated with Cognition in Primary Lateral Sclerosis Patients
Canu, E., Agosta, F., Galantucci, S., Chiò, A., Riva, N., Silani, V., Falini, A., Comı, G., & Filippi, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082017 · Cited by 50
Whole-Brain Analysis of Amyotrophic Lateral Sclerosis by Using Echo-Planar Spectroscopic Imaging
Verma, G., Woo, J. H., Chawla, S., Wang, S., Sheriff, S., Elman, L. B., McCluskey, L. F., Grossman, M., Melhem, E. R., Maudsley, A. A., et al. (2013) · Radiology · doi:10.1148/radiol.13121148 · Cited by 50
Differential corticospinal tract degeneration in homozygous 'D90A' SOD-1 ALS and sporadic ALS
Blain, C. R. V., Brunton, S. L., Williams, V. C., Leemans, A., Turner, M. R., Andersen, P. M., Catani, M., Stanton, B. R., Ganesalingham, J., Jones, D. K., et al. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.236018 · Cited by 50
Self-citationGlybina, I. V., Kennedy, A., Ashton, P., Abrams, G. W., & Iezzi, R. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2831 · Cited by 49
Abdulla, S., Vielhaber, S., Körner, S., Machts, J., Heinze, H., Dengler, R., & Petri, S. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6955-6 · Cited by 49
Picone, R. P., & Kendall, D. A. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1062 · Cited by 49
Pagani, M., Öberg, J., Carli, F. D., Calvo, A., Moglia, C., Canosa, A., Nobili, F. M., Morbelli, S. D., Fania, P., Cistaro, A., et al. (2015) · Human Brain Mapping · doi:10.1002/hbm.23078 · Cited by 48
Primary lateral sclerosis and the amyotrophic lateral sclerosis–frontotemporal dementia spectrum
Agarwal, S., Highton‐Williamson, E., Caga, J., Matamala, J. M., Dharmadasa, T., Howells, J., Zoing, M. C., Shibuya, K., Geevasinga, N., Vucic, S., et al. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8917-5 · Cited by 49
Diffusion Tensor Imaging in Sporadic and Familial (D90A SOD1) Forms of Amyotrophic Lateral Sclerosis
Stanton, B. R., Shinhmar, D., Turner, M. R., Williams, V. C., Williams, S., Blain, C. R. V., Giampietro, V., Catani, M., Leigh, P. N., Andersen, P. M., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.527 · Cited by 49
Self-citationHuman iPSC co-culture model to investigate the interaction between microglia and motor neurons
Vahsen, B. F., Gray, E., Candalija, A., Cramb, K. M. L., Scaber, J., Dafinca, R., Katsikoudi, A., Xu, Y., Farrimond, L. E., Wade‐Martins, R., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16896-8 · Cited by 52
Self-citationGargiulo, S., Anzilotti, S., Coda, A. R. D., Gramanzini, M., Greco, A., Panico, M., Vinciguerra, A., Zannetti, A., Vicidomini, C., Dollé, F., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3311-y · Cited by 48
Chauveau, F., Becker, G., & Boutin, H. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05425-w · Cited by 54
Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis
Turner, M. R., Hammers, A., Allsop, J. M., Al‐Chalabi, A., Shaw, C. E., Brooks, D. J., Leigh, P. N., & Andersen, P. M. (2007) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960701538734 · Cited by 48
Self-citationPseudoreference Regions for Glial Imaging with 11C-PBR28: Investigation in 2 Clinical Cohorts
Albrecht, D., Normandin, M. D., Shcherbinin, S., Wooten, D., Schwarz, A. J., Zürcher, N. R., Barth, V., Guehl, N. J., Akeju, O., Atassi, N., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.178335 · Cited by 50
Self-citationAmyotrophic lateral sclerosis: The complement and inflammatory hypothesis
Kjældgaard, A.-L., Pilely, K., Olsen, K. S., Pedersen, S. W., Lauritsen, A. Ø., Møller, K., & Garred, P. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.06.007 · Cited by 45
Ikawa, M., Okazawa, H., Nakamoto, Y., & Yoneda, M. (2020) · Antioxidants · doi:10.3390/antiox9090861 · Cited by 48
Azam, S., Haque, M. E., Kim, I., & Choi, D. (2021) · Cells · doi:10.3390/cells10010150 · Cited by 46
Potential Roles of the WNT Signaling Pathway in Amyotrophic Lateral Sclerosis
Jiang, X., Guan, Y., Zhao, Z., Meng, F., Wang, X., Gao, X., Liu, J., Chen, Y., Zhou, F., Zhou, F., et al. (2021) · Cells · doi:10.3390/cells10040839 · Cited by 48
Apathy in amyotrophic lateral sclerosis: insights from Dimensional Apathy Scale
Santangelo, G., Siciliano, M., Trojano, L., Femiano, C., Monsurrò, M. R., Tedeschi, G., & Trojsi, F. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1313865 · Cited by 45
The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis
Pikatza‐Menoio, O., Elicegui, A., Bengoetxea, X., Naldaiz‐Gastesi, N., de Munaín, A. L., Gereñu, G., Gil-Bea, F. J., & Alonso‐Martín, S. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070671 · Cited by 50
NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS
Jiménez-Villegas, J., Ferraiuolo, L., Mead, R. J., Shaw, P. J., Cuadrado, A., & Rojo, A. I. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.022 · Cited by 44
Cortical activation during motor imagery is reduced in Amyotrophic Lateral Sclerosis
Stanton, B. R., Williams, V. C., Leigh, P. N., Williams, S., Blain, C. R. V., Giampietro, V., & Simmons, A. (2007) · Brain Research · doi:10.1016/j.brainres.2007.07.044 · Cited by 45
Self-citationAxonal Ion Channel Dysfunction inC9orf72Familial Amyotrophic Lateral Sclerosis
Geevasinga, N., Menon, P., Howells, J., Nicholson, G. A., Kiernan, M. C., & Vucic, S. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2940 · Cited by 44
CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis
Gray, E., Thompson, A. G., Wuu, J., Pelt, J., Talbot, K., Benatar, M. G., & Turner, M. R. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51114 · Cited by 45
Self-citationSensory Involvement in Amyotrophic Lateral Sclerosis
Rubio, M. Á., Herrando‐Grabulosa, M., & Navarro, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415521 · Cited by 48
Bartus, R. T., Bétourné, A., Basile, A. S., Peterson, B. L., Glass, J. D., & Boulis, N. M. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.10.006 · Cited by 43
Potential structural and functional biomarkers of upper motor neuron dysfunction in ALS
Grieve, S. M., Menon, P., Korgaonkar, M. S., Gomes, L. J., Foster, S., Kiernan, M. C., & Vucic, S. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1074707 · Cited by 43
Trojsi, F., Caiazzo, G., Corbo, D., Piccirillo, G., Cristillo, V., Femiano, C., Ferrantino, T., Cirillo, M., Monsurrò, M. R., Esposito, F., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119045 · Cited by 43
Cortical contributions to the flail leg syndrome: Pathophysiological insights
Menon, P., Geevasinga, N., Yiannikas, C., Kiernan, M. C., & Vucic, S. (2016) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2016.1145232 · Cited by 43
Positron Emission Tomography Molecular Imaging Biomarkers for Amyotrophic Lateral Sclerosis
Chew, S., & Atassi, N. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00135 · Cited by 43
Metadata
- Authors
- Turner, M. R., Cagnin, A., Turkheimer, F. E., Miller, C. C. J., Shaw, C. E., Brooks, D. J., Leigh, P. N., & Banati, R. B.
- Affiliations
- King's College London (GB)
- University of Padua (IT)
- Hammersmith Hospital (GB)
- Corresponding author
- Turner, M.R
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 15
- Issue
- 3
- Pages
- 601-609
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2019706623
- Cited by
- 737
- References
- 90
- Citations by year
- 2026: 15 · 2025: 23 · 2024: 37 · 2023: 31 · 2022: 40 · 2021: 52 · 2020: 52 · 2019: 43 · 2018: 43 · 2017: 44 · 2016: 42 · 2015: 42 · 2014: 47 · 2013: 42 · 2012: 27
- FWCI
- 15.87
- Type
- journal article
- Language
- en
- Open access
- green
- doaj.org
- Licence
- Locations
- Neurobiology of Disease (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research Portal (King's College London) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- amyotrophic lateral sclerosis, microglial activation, [11C]PK11195, positron emission tomography, translocator protein (TSPO), motor cortex, passive optical networks, dorsolateral prefrontal cortex, thalamus, upper motor neuron signs, neuroinflammation, neuropathology
- MeSH terms
- Adult, Amyotrophic Lateral Sclerosis, Brain, Female, Humans, Isoquinolines, Male, Middle Aged, Tomography, Emission-Computed, Microglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review